Asymptomatic Congenital CMV Treatment

NCT03301415 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

NIH

Sponsor class

Stopped Safety signal

Conditions

Congenital Cytomegalovirus Infection

Interventions

DRUG: Valganciclovir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)